JP2013520960A5 - - Google Patents

Download PDF

Info

Publication number
JP2013520960A5
JP2013520960A5 JP2012540193A JP2012540193A JP2013520960A5 JP 2013520960 A5 JP2013520960 A5 JP 2013520960A5 JP 2012540193 A JP2012540193 A JP 2012540193A JP 2012540193 A JP2012540193 A JP 2012540193A JP 2013520960 A5 JP2013520960 A5 JP 2013520960A5
Authority
JP
Japan
Prior art keywords
protein
amount
cell
human subject
degradation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012540193A
Other languages
English (en)
Japanese (ja)
Other versions
JP5846608B2 (ja
JP2013520960A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2011/055570 external-priority patent/WO2011108766A1/en
Publication of JP2013520960A publication Critical patent/JP2013520960A/ja
Publication of JP2013520960A5 publication Critical patent/JP2013520960A5/ja
Application granted granted Critical
Publication of JP5846608B2 publication Critical patent/JP5846608B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012540193A 2010-03-03 2011-03-03 ｉＰＳ細胞由来の神経細胞を用いた蛋白質ミスフォールディング病の診断方法 Expired - Fee Related JP5846608B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30992710P 2010-03-03 2010-03-03
US61/309,927 2010-03-03
PCT/JP2011/055570 WO2011108766A1 (en) 2010-03-03 2011-03-03 METHOD FOR DIAGNOSING A PROTEIN MISFOLDING DISEASE USING NERVE CELLS DERIVED FROM iPS CELLS

Publications (3)

Publication Number Publication Date
JP2013520960A JP2013520960A (ja) 2013-06-10
JP2013520960A5 true JP2013520960A5 (enExample) 2014-06-26
JP5846608B2 JP5846608B2 (ja) 2016-01-20

Family

ID=44542394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012540193A Expired - Fee Related JP5846608B2 (ja) 2010-03-03 2011-03-03 ｉＰＳ細胞由来の神経細胞を用いた蛋白質ミスフォールディング病の診断方法

Country Status (3)

Country Link
US (1) US9097727B2 (enExample)
JP (1) JP5846608B2 (enExample)
WO (1) WO2011108766A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642334B2 (en) 2009-02-17 2014-02-04 Memorial Sloan Kettering Cancer Center Methods of neural conversion of human embryonic stem cells
ES2747803T3 (es) * 2010-05-25 2020-03-11 Memorial Sloan Kettering Cancer Center Método de diferenciación a nociceptores de células madre embrionarias humanas y sus usos
AU2012332269B2 (en) 2011-11-04 2018-05-31 Memorial Sloan-Kettering Cancer Center Midbrain dopamine (DA) neurons for engraftment
WO2013140927A1 (ja) * 2012-03-21 2013-09-26 国立大学法人京都大学 アルツハイマー病の治療薬および/または予防薬のスクリーニング方法
JP6756610B2 (ja) 2013-04-26 2020-09-16 メモリアル スローン ケタリング キャンサー センター 多分化能細胞および多能性細胞の分化を方向付けることによって発生させる皮質介在ニューロンおよびその他のニューロン細胞
US20160030484A1 (en) * 2014-08-04 2016-02-04 University Of Kansas Mammalian pluripotent stem cells, methods for their production, and uses thereof
EP3315604A4 (en) 2015-06-25 2018-12-26 Kaneka Corporation Liquid injection method
EP3817753A1 (en) * 2018-07-03 2021-05-12 Universidad del País Vasco - Euskal Herriko Unibertsitatea Cellular aggregates for use in vascularisation therapy
WO2020165615A1 (en) * 2019-02-14 2020-08-20 Omnion Research International D.O.O. Method of transformation of hair folicle cells into neurons, method and scale for estimating risk for onset of a particular brain disease
JP7333579B2 (ja) * 2019-05-08 2023-08-25 国立大学法人東京工業大学 アルツハイマー疾患モデル神経細胞及びその製造方法、並びにその神経細胞を用いたアルツハイマー病作用薬物のスクリーニング方法
EP3978595A4 (en) * 2019-05-31 2023-07-05 Kyoto University INFORMATION PROCESSING DEVICE, SCREENING DEVICE, INFORMATION PROCESSING METHOD, SCREENING METHOD AND PROGRAM
WO2020241836A1 (ja) * 2019-05-31 2020-12-03 国立大学法人京都大学 情報処理装置、スクリーニング装置、情報処理方法、スクリーニング方法、及びプログラム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE481498T1 (de) * 2002-04-26 2010-10-15 Takeda Pharmaceutical Verfahren zur messung von neprilysinaktivität
WO2004081172A2 (en) 2003-03-12 2004-09-23 Reliance Life Sciences Pvt. Ltd. Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells
ZA200401646B (en) * 2003-03-12 2004-06-07 Reliance Life Sciences Pvt Ltd Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells.
WO2010008486A2 (en) * 2008-06-24 2010-01-21 Parkinsons Institute Pluripotent cell lines and methods of use thereof

Similar Documents

Publication Publication Date Title
Frontzkowski et al. Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading
Onos et al. Enhancing face validity of mouse models of Alzheimer’s disease with natural genetic variation
Mander et al. Sleep: a novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer's disease?
Gaiteri et al. Genetic variants in Alzheimer disease—molecular and brain network approaches
Cushing et al. Impaired hippocampal-cortical interactions during sleep in a mouse model of Alzheimer’s disease
Moya-Alvarado et al. Neurodegeneration and Alzheimer's disease (AD). What can proteomics tell us about the Alzheimer's brain?
Naudí et al. Lipidomics of human brain aging and Alzheimer's disease pathology
Liu et al. Olfactory deficit: a potential functional marker across the Alzheimer’s disease continuum
Gómez-Sintes et al. Mice with a naturally occurring DISC1 mutation display a broad spectrum of behaviors associated to psychiatric disorders
Ogonowski et al. Systematic review: microRNAs as potential biomarkers in mild cognitive impairment diagnosis
EA201590175A1 (ru) Скрининг, диагностика и прогнозирование аутизма и других нарушений развития
El Alaoui et al. Long-term effectiveness and outcome predictors of therapist-guided internet-based cognitive–behavioural therapy for social anxiety disorder in routine psychiatric care
Jarek et al. Evaluating p-tau217 and p-tau231 as biomarkers for early diagnosis and differentiation of Alzheimer’s disease: a narrative review
TW201606304A (zh) 測定治療反應之方法
Mohamet et al. Familial Alzheimer’s disease modelling using induced pluripotent stem cell technology
Qiu et al. Alzheimer's disease progression model based on integrated biomarkers and clinical measures
Faisal et al. Preclinical trials in Alzheimer’s disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice
Vandenberghe The relationship between amyloid deposition, neurodegeneration, and cognitive decline in dementia
Baxter et al. Investigation of associations between Piezo1 mechanoreceptor gain-of-function variants and glaucoma-related phenotypes in humans and mice
Kuang et al. Default mode network analysis of APOE genotype in cognitively unimpaired subjects based on persistent homology
Jiao et al. Temporal dynamics and composition of ocular surface microbiota in C57BL/6J mice: uncovering a 12h ultradian rhythm
Castillo-Mariqueo et al. Translational modeling of psychomotor function in normal and AD-pathological aging with special concerns on the effects of social isolation
Striebel et al. Knockout of fractalkine receptor Cx3cr1 does not alter disease or microglial activation in prion-infected mice
Dehkordi et al. Identification of markers for neurescence through transcriptomic profiling of postmortem human brains
Danter Tracing Alzheimer’s genetic footprints: a pioneering longitudinal study using artificial intelligence to unravel mutation-driven risks and progression in virtual patients; part 1–the APOE genotypes